Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemens Neufert

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|July 19, 2017
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression ProfilesFriederike Fuchs, Daniela Schillinger, Raja Atreya, et al.
Gut|August 21, 2016
Blockade of αEβ7 integrin suppresses accumulation of CD8<sup>+</sup> and Th9 lymphocytes from patients with IBD in the inflamed gut in vivoSebastian Zundler, Daniela Schillinger, Anika Fischer, et al.
International Journal of Molecular Sciences|June 2, 2021
Dynamic Imaging of IEL-IEC Co-Cultures Allows for Quantification of CD103-Dependent T Cell MigrationKarin Enderle, Martin Dinkel, Eva-Maria Spath, et al.
Cancers|March 25, 2022
Targeting STAT3 Signaling in COL1+ Fibroblasts Controls Colitis-Associated Cancer in MiceChristina Heichler, Anabel Schmied, Karin Enderle, et al.
Frontiers in Immunology|September 14, 2023
Novel T cell/organoid culture system allows <i>ex vivo</i> modeling of intestinal graft-versus-host diseaseDiana M Matthe, Martin Dinkel, Benjamin Schmid, et al.
Gut|January 20, 2016
IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivoKristina Scheibe, Ingo Backert, Stefan Wirtz, et al.
Inflammatory Bowel Diseases|July 15, 2017
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative ColitisCaroline J Voskens, Anika Fischer, Susanne Roessner, et al.
Gastroenterology|February 16, 2012
A variant of Smurf2 protects mice against colitis-associated colon cancer by inducing transforming growth factor β signalingHeike Dornhoff, Christoph Becker, Stefan Wirtz, et al.
European Journal of Gastroenterology & Hepatology|May 25, 2021
Computer-aided detection of colorectal polyps using a newly generated deep convolutional neural network: from development to first clinical experienceLukas Pfeifer, Clemens Neufert, Moritz Leppkes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cellsSabine Dominitzki, Massimo C Fantini, Clemens Neufert, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|July 19, 2017
Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression ProfilesFriederike Fuchs, Daniela Schillinger, Raja Atreya, et al.
Gut|August 21, 2016
Blockade of αEβ7 integrin suppresses accumulation of CD8<sup>+</sup> and Th9 lymphocytes from patients with IBD in the inflamed gut in vivoSebastian Zundler, Daniela Schillinger, Anika Fischer, et al.
International Journal of Molecular Sciences|June 2, 2021
Dynamic Imaging of IEL-IEC Co-Cultures Allows for Quantification of CD103-Dependent T Cell MigrationKarin Enderle, Martin Dinkel, Eva-Maria Spath, et al.
Cancers|March 25, 2022
Targeting STAT3 Signaling in COL1+ Fibroblasts Controls Colitis-Associated Cancer in MiceChristina Heichler, Anabel Schmied, Karin Enderle, et al.
Frontiers in Immunology|September 14, 2023
Novel T cell/organoid culture system allows <i>ex vivo</i> modeling of intestinal graft-versus-host diseaseDiana M Matthe, Martin Dinkel, Benjamin Schmid, et al.
Gut|January 20, 2016
IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivoKristina Scheibe, Ingo Backert, Stefan Wirtz, et al.
Inflammatory Bowel Diseases|July 15, 2017
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative ColitisCaroline J Voskens, Anika Fischer, Susanne Roessner, et al.
Gastroenterology|February 16, 2012
A variant of Smurf2 protects mice against colitis-associated colon cancer by inducing transforming growth factor β signalingHeike Dornhoff, Christoph Becker, Stefan Wirtz, et al.
European Journal of Gastroenterology & Hepatology|May 25, 2021
Computer-aided detection of colorectal polyps using a newly generated deep convolutional neural network: from development to first clinical experienceLukas Pfeifer, Clemens Neufert, Moritz Leppkes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cellsSabine Dominitzki, Massimo C Fantini, Clemens Neufert, et al.
Pageof 8